003060 — Aprogen Biologics Balance Sheet

0.000.00%

Last trade - 00:00

HealthcareHighly SpeculativeSmall CapSucker Stock

Market Cap
KR₩130bn
Enterprise Value
KR₩263bn
Revenue
KR₩67bn

Annual balance sheet for Aprogen Biologics, fiscal year end - December 31st, KRW millions except per share, conversion factor applied.

	2020 December 31st	2021 December 31st	2022 December 31st	2023 December 31st	2024 December 31st
Period Length:	—	—	—	—	—
Source:	Annual Audited Accounts	Annual Audited Accounts	Annual Audited Accounts	Annual Audited Accounts	Annual Audited Accounts
Standards:	IFRS	IFRS	IFRS	IFRS	IFRS
Status:	Final	Final	Final	Final	Final
Cash
Short Term Investments
Cash and Short Term Investments	205,075	124,935	99,074	10,053	38,319
Net Total Accounts Receivable
Net Total Receivables	120,990	217,997	87,497	24,040	23,607
Total Inventory
Prepaid Expenses
Total Other Current Assets
Total Current Assets	336,523	353,474	240,608	84,857	115,200
Gross Property, Plant And Equipment
Accumulated Depreciation
Net Property, Plant And Equipment	19,801	18,857	323,773	318,212	321,458
Net Intangible Assets
Long Term Investments
Long Term Notes Receivable
Other Long Term Assets
Total Assets	615,309	614,621	676,103	589,397	590,984
Accounts Payable
Payable / Accrued
Accrued Expenses
Notes Payable / Short Term Debt
Current Portion of Long Term Debt / Capital Leases
Total Other Current Liabilities
Total Current Liabilities	8,675	9,449	161,106	157,938	147,509
Long Term Debt
Capital Lease Obligations
Total Long Term Debt
Total Debt
Deferred Income Tax
Minority Interest
Total Other Liabilities
Total Funded Status
Total Liabilities	109,914	106,682	254,384	220,705	212,493
Common Stock
Additional Paid In Capital
Retained Earnings (Accumulated Deficit)
Treasury Stock
ESOP Debt Guarantee
Unrealized Gain / Loss
Other Equity
Total Equity	505,395	507,939	421,719	368,691	378,491
Total Liabilities & Shareholders' Equity	615,309	614,621	676,103	589,397	590,984
Total Common Shares Outstanding